16 January 2017
WHO has been working closely with national governments to provide economic data on the burden of disease, the cost effectiveness of vaccines, and the projected implementation costs of immunization programmes in their countries to help decision makers better allocate their resources to reach universal health coverage.
A series of tools and resource documents have been developed to assess the economic and social benefits of introducing vaccines.
4 January 2018
As schools reopened after the winter break, children in the Ukhia sub-district of Cox’s Bazar, Bangladesh, lined up not only to receive new books, but also a dose of diphtheria tetanus (DT) vaccine.
School children living in areas close to the Rohingya camps are being administered a dose of DT vaccine as part of the diphtheria outbreak response.
3 January 2018
WHO prequalified the first conjugate vaccine for typhoid, Bharat Biotech’s Typbar-TCV®. Typhoid conjugate vaccines (TCVs) are innovative products that have longer-lasting immunity than older vaccines, require fewer doses, and can be given to young children through routine childhood immunization programs.
The fact that the vaccine has been prequalified by WHO means that it meets acceptable standards of quality, safety and efficacy. This makes the vaccine eligible for procurement by UN agencies, such as UNICEF, and Gavi, the Vaccine Alliance.
20 December 2017
This was a year of major achievements for WHO - from progress towards measles elimination, polio eradication and global immunization coverage, responding to cholera and yellow fever outbreaks, to shaping global policy and the election of a new Director-General.
Review and relive some of the biggest health stories from WHO in 2017.
86%of infants worldwide vaccinated with 3 doses of DTP vaccine in 2016Immunization coverage fact sheet
1 in 10infants did not receive any vaccinations in 20162016 immunization coverage data
90 000estimated deaths from measles in 2016Measles fact sheet